Publications en collaboration avec des chercheurs de Leeds and York Partnership NHS Foundation Trust (12)

2020

  1. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

  2. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia – data from the OPTiMiSE trial

    Psychiatry Research, Vol. 289

  3. The identification, assessment and management of difficult-to-treat depression: An international consensus statement

    Journal of Affective Disorders, Vol. 267, pp. 264-282

2019

  1. Distinct associations between fronto-striatal glutamate concentrations and callous-unemotional traits and proactive aggression in disruptive behavior

    Cortex, Vol. 121, pp. 135-146

  2. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436

  3. Transdiagnostic dimensions of psychopathology at first episode psychosis: Findings from the multinational EU-GEI study

    Psychological Medicine, Vol. 49, Núm. 8, pp. 1378-1391

2018

  1. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807

2017

  1. The association between comorbid autism spectrum disorders and antipsychotic treatment failure in early-onset psychosis: A historical cohort study using electronic health records

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. e1233-e1241

2016

  1. Autism spectrum disorder and schizophrenia: Boundaries and uncertainties

    BJ Psych Advances, Vol. 22, Núm. 5, pp. 316-324

  2. BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents

    Journal of Psychopharmacology, Vol. 30, Núm. 5, pp. 416-421

2015

  1. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: A review of current evidence and directions for future research

    Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 574-583

2014

  1. Common variant at 16p11.2 conferring risk of psychosis

    Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114